Design and cohort description of the InterAct Project: An examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study

Diabetologia

Volumn 54, Issue 9, 2011, Pages 2272-2282

  Langenberg, C ^a   Sharp, S ^a   Forouhi, N G ^a   Franks, P W ^b   Schulze, M B ^c   Kerrison, N ^a   Ekelund, U ^a   Barroso, I ^d   Panico, S ^e   Tormo, M J ^f   Spranger, J ^g   Griffin, S ^a   van der Schouw, Y T ^h   Amiano, P ⁱ   Ardanaz, E ^j   Arriola, L ⁱ   Balkau, B ^k   Barricarte, A ^l   Beulens, J W J ^h   Boeing, H ^c   Bueno de Mesquita, H B ^m   Buijsse, B ^c   Lopez, Chirlaque ⁿ   Clavel Chapelon, F ^k   Crowe, F L ^o   de Lauzon Guillan, B ^k   Deloukas, P ^d   Dorronsoro, M ⁱ   Drogan, D ^c   Froguel, P ^p   Gonzalez, C ^q   Grioni, S ^r   Groop, L ^s   Groves, C ^o   Hainaut, P ^t   Halkjaer, J ^u   Hallmans, G ^v   Hansen, T ^w   Huerta Castano J M ⁿ   Kaaks, R ^x   Key, T J ^o   Khaw, K T ^y   Koulman, A ^z   Mattiello, A ^e   Navarro, C ⁿ   Nilsson, P ^b   Norat, T ^p   Overvad, K ^aa   Palla, L ^a   Palli, D ^ab   Pedersen, O ^w   Peeters, P H ^h   Quiros J R ^ac   Ramachandran, A ^ad   Rodriguez Suarez, L ^ac   Rolandsson, O ^v   Romaguera, D ^p   Romieu, I ^t   Sacerdote, C ^ae   Sanchez M J ^af   Sandbaek, A ^aa   Slimani, N ^t   Sluijs, I ^h   Spijkerman, A M W ^m   Teucher, B ^x   Tjonneland, A ^u   Tumino, R ^ag   van der A, D L ^m   Verschuren, W M M ^m   Tuomilehto, J ^ah   Feskens, E ^ai   McCarthy, M ^o   Riboli, E ^p   Wareham, N J ^a   more..

^a MRC EPIDEMIOLOGY UNIT   (United Kingdom)

^b LUND UNIVERSITY   (Sweden)

^c GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^d WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^e UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^f DEPARTMENT OF EPIDEMIOLOGY   (Spain)

^g CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^h UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

ⁱ Public Health Division of Gipuzkoa   (Spain)

^j INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^k INSERM   (France)

^l Epidemiology   (Spain)

^m NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

ⁿ Murcia Regional Health Authority   (Spain)

^o UNIVERSITY OF OXFORD   (United Kingdom)

^p IMPERIAL COLLEGE LONDON   (United Kingdom)

^q CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^r NATIONAL CANCER INSTITUTE   (Italy)

^s LUND UNIVERSITY HOSPITAL   (Sweden)

^t INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^u DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^v UMEÅ UNIVERSITY   (Sweden)

^w HAGEDORN RESEARCH INSTITUTE   (Denmark)

^x GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^y UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^z MRC HUMAN NUTRITION RESEARCH   (United Kingdom)

^aa Danish Research Centre for Cancer Diagnosis in Primary Care CaP   (Denmark)

^ab CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^ac Asturias Health and Health Care Council   (Spain)

^ad Research Foundation   (India)

^ae Center for Cancer Prevention   (Italy)

^af ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^ag Cancer Registry and Histopathology Unit   (Italy)

^ah UNIVERSITY OF HELSINKI   (Finland)

^ai WAGENINGEN UNIVERSITY   (Netherlands)

more..

Author keywords

Cohort studies; Diabetes mellitus; Epidemiologic research design; Gene lifestyle interaction; Genetic epidemiology; Type 2 diabetes

Indexed keywords

ADULT; AGE; ARTICLE; BEHAVIOR; BODY MASS; CASE STUDY; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETOGENESIS; DIET; EUROPE; FEMALE; FOLLOW UP; GENDER; GENE LOCUS; GENETIC SUSCEPTIBILITY; HEREDITY; HUMAN; INCIDENCE; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RANDOMIZATION; RISK ASSESSMENT; SEX DIFFERENCE; WAIST CIRCUMFERENCE;

COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DIET; EUROPE; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; INTERNATIONAL COOPERATION; LIFE STYLE; MALE; MIDDLE AGED; MOTOR ACTIVITY; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 80054698404     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-011-2182-9     Document Type: Article

References (32)

1. Sladek R, Rocheleau G, Rung J et al (2007) A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445:881-885
2. Saxena R, Voight BF, Lyssenko V et al (2007) Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316:1331-1336 (Pubitemid 46871653)
3. Scott LJ, Mohlke KL, Bonnycastle LL,Willer CJ, Li Y, DurenWL et al (2007) A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316:1341-1345 (Pubitemid 46871655)
4. Zeggini E, Weedon MN, Lindgren CM et al (2007) Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 316:1336-1341 (Pubitemid 46871654)
5. Steinthorsdottir V, Thorleifsson G, Reynisdottir I et al (2007) A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet 39:770-775 (Pubitemid 46848592)
6. Zeggini E, Scott LJ, Saxena R et al (2008) Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet 40:638-645 (Pubitemid 351601209)
7. Altshuler D, Daly M (2007) Guilt beyond a reasonable doubt. Nat Genet 39:813-815 (Pubitemid 47014482)
8. Manolio TA (2009) Cohort studies and the genetics of complex disease. Nat Genet 41:5-6
9. Bingham S, Riboli E (2004) Diet and cancer-the European Prospective Investigation into Cancer and Nutrition. Nat Rev Cancer 4:206-215 (Pubitemid 38337500)
10. Riboli E, Hunt KJ, Slimani N et al (2002) European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 5:1113-1124 (Pubitemid 36313608)
11. Slimani N, Deharveng G, CharrondiFre RU et al (1999) Structure of the standardized computerized 24-h diet recall interview used as reference method in the 22 centers participating in the EPIC project. Comput Meth Programs Biomed 58:251-266 (Pubitemid 29074674)
12. Day N, Oakes S, Luben R et al (1999) EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. Br J Cancer 80(Suppl 1):95-103 (Pubitemid 29389613)
13. Wareham NJ, Jakes RW, Rennie KL et al (2003) Validity and repeatability of a simple index derived from the short physical activity questionnaire used in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study. Public Health Nutr 6:407-413 (Pubitemid 36749764)
14. Brage S, Ekelund U, Brage N et al (2007) Hierarchy of individual calibration levels for heart rate and accelerometry to measure physical activity. J Appl Physiol 103:682-692 (Pubitemid 47204988)
15. Martyn CN, Barker DJ, Osmond C (1996) Mothers' pelvic size, fetal growth, and death from stroke and coronary heart disease in men in the UK. Lancet 348:1264-1268 (Pubitemid 26377237)
16. Pischon T, Boeing H, Hoffmann K et al (2008) General and abdominal adiposity and risk of death in Europe. N Engl J Med 359:2105-2120
17. McCarthy MI, Hirschhorn JN (2008) Genome-wide association studies: potential next steps on a genetic journey. Hum Mol Genet 17:R156-R165
18. McCarthy MI, Zeggini E (2009) Genome-wide association studies in type 2 diabetes. Curr Diab Rep 9:164-171
19. Timpson NJ, Lindgren CM, Weedon MN et al (2009) Adiposity-related heterogeneity in patterns of type 2 diabetes susceptibility observed in genome-wide association data. Diabetes 58:505-510
20. Florez JC, Jablonski KA, Bayley N et al (2006) TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med 355:241-250 (Pubitemid 44079339)
21. Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047-1053 (Pubitemid 38579764)
22. Shaw JE, Sicree RA, Zimmet PZ (2010) Global estimates of the prevalence of diabetes for 2010 and 2030. Diab Res Clin Pract 87:4-14
23. Jansson SP, Andersson DK, Svardsudd K (2007) Prevalence and incidence rate of diabetes mellitus in a Swedish community during 30 years of follow-up. Diabetologia 50:703-710 (Pubitemid 46355829)
24. Soriguer F, Rojo-Martinez G, Almaraz MC et al (2008) Incidence of type 2 diabetes in southern Spain (Pizarra Study). Eur J Clin Invest 38:126-133 (Pubitemid 351147804)
25. Forouhi NG, Luan J, Hennings S, Wareham NJ (2007) Incidence of type 2 diabetes in England and its association with baseline impaired fasting glucose: the Ely Study 1990-2000. Diabet Med 24:200-207 (Pubitemid 46174945)
26. Rathmann W, Strassburger K, Heier M, Holle R, Thorand B, Giani G et al (2009) Incidence of type 2 diabetes in the elderly German population and the effect of clinical and lifestyle risk factors: KORA S4/F4 cohort study. Diabet Med 26:1212-1219
27. Bonora E, Kiechl S, Willeit J et al (2004) Population-based incidence rates and risk factors for type 2 diabetes in white individuals: the Bruneck Study. Diabetes 53:1782-1789 (Pubitemid 38857036)
28. Arteagoitia JM, Larranaga MI, Rodriguez JL, Fernandez I, Pinies JA (2003) Incidence, prevalence and coronary heart disease risk level in known type 2 diabetes: a sentinel practice network study in the Basque Country, Spain. Diabetologia 46:899-909 (Pubitemid 36966120)
29. Valdes S, Botas P, Delgado E, Alvarez F, Cadorniga FD (2007) Population-based incidence of type 2 diabetes in northern Spain: the Asturias Study. Diabetes Care 30:2258-2263 (Pubitemid 47359028)
30. Meisinger C, Thorand B, Schneider A, Stieber J, Doring A, Lowel H (2002) Sex differences in risk factors for incident type 2 diabetes mellitus: the MONICA Augsburg cohort study. Arch Intern Med 162:82-89 (Pubitemid 34073405)
31. Hippisley-Cox J, Coupland C, Robson J, Sheikh A, Brindle P (2009) Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore. BMJ 338:b880
32. Marteau TM, French DP, Griffin SJ et al. (2010) Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours. Cochrane Database of Systematic Reviews 2010, Issue 10, Art. no.: CD007275. doi:10.1002/14651858. CD007275.pub2.